IOM Committee Members Respond to Endocrine Society Vitamin D Guideline
2012/03/23 by Clifford J. Rosen, Steven A. Abrams, John F. Aloia +15 · 25 citations
Medicine · Nursing · #Vitamin D Research Studies #Vitamin C and Antioxidants Research #Bone health and osteoporosis research
paper · pdf · doi:10.1210/jc.2011-2218
Abstract
In early 2011, a committee convened by the Institute of Medicine issued a report on the Dietary Reference Intakes for calcium and vitamin D. The Endocrine Society Task Force in July 2011 published a guideline for the evaluation, treatment, and prevention of vitamin D deficiency. Although these reports are intended for different purposes, the disagreements concerning the nature of the available data and the resulting conclusions have caused confusion for clinicians, researchers, and the public. In this commentary, members of the Institute of Medicine committee respond to aspects of The Endocrine Society guideline that are not well supported and in need of reconsideration. These concerns focus on target serum 25-hydroxyvitamin D levels, the definition of vitamin D deficiency, and the question of who constitutes a population at risk vs. the general population.
Cited by
- Impaired vitamin D metabolism in CKD. [europepmc]
- Large, single-dose, oral vitamin D supplementation in adult populations: a systematic review. [europepmc]
- Vitamin D-binding protein and vitamin D status of black Americans and white Americans. [europepmc]
- Vitamin D and diabetes. [europepmc]
- Low vitamin D levels are common in patients with epilepsy. [europepmc]
- Vitamin D and the development of allergic disease: how important is it? [europepmc]
- The role of vitamin D in reproductive health--a Trojan Horse or the Golden Fleece? [europepmc]
- Association between 25(OH)D Level, Ultraviolet Exposure, Geographical Location, and Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis. [europepmc]
- The Associations of Serum Lipids with Vitamin D Status. [europepmc]
- 25-Hydroxyvitamin D Status and Risk for Colorectal Cancer and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Epidemiological Studies. [europepmc]
- Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO). [europepmc]
- Vitamin D as a follicular marker of human oocyte quality and a serum marker of in vitro fertilization outcome. [europepmc]
- Vitamin D for the management of multiple sclerosis. [europepmc]
- Vitamin D testing and treatment: a narrative review of current evidence. [europepmc]
- Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial. [europepmc]
- Vitamin D Status, Calcium Intake and Risk of Developing Type 2 Diabetes: An Unresolved Issue. [europepmc]
- Vitamin D Binding Protein and the Biological Activity of Vitamin D. [europepmc]
- A Brief Review of the Effects of Vitamin D on Multiple Sclerosis. [europepmc]
- Vitamin D-Binding Protein in Pregnancy and Reproductive Health. [europepmc]
- Skeletal Muscle and the Maintenance of Vitamin D Status. [europepmc]
- Vitamin D Metabolism and Guidelines for Vitamin D Supplementation. [europepmc]
- Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. [europepmc]
- Clinical Practice in the Prevention, Diagnosis and Treatment of Vitamin D Deficiency: A Central and Eastern European Expert Consensus Statement. [europepmc]
- Vitamin D: Before, during and after Pregnancy: Effect on Neonates and Children. [europepmc]
- Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS). [europepmc]
Related